Shopping Cart
- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
DS-1040 Tosylate is a thrombin-activated fibrinolysis inhibitor (TAFIa) inhibitor, also a fibrinolysis enhancer, inhibiting TAFIa and carboxypeptidase N, reducing fibrin clots in the lungs, useful in thromboembolic disease research.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 2 mg | $119 | 5 days | |
| 25 mg | $614 | 8-10 weeks | |
| 50 mg | $798 | 8-10 weeks | |
| 100 mg | $1,360 | 8-10 weeks | 
| Description | DS-1040 Tosylate is a thrombin-activated fibrinolysis inhibitor (TAFIa) inhibitor, also a fibrinolysis enhancer, inhibiting TAFIa and carboxypeptidase N, reducing fibrin clots in the lungs, useful in thromboembolic disease research. | 
| Targets&IC50 |  TAFIa (human):5.92 nM, TAFIa (rat):8.01 nM | 
| In vitro | DS-1040 Tosylate inhibited human carboxypeptidase N (CPN) in vitro with an IC50 of 3.02 mM.[1] | 
| In vivo | Methods: DS-1040 Tosylate (0.016, 0.031, 0.063, 0.13, 0.25, 0.50 mg/kg, intravenous injection) was administered to mice with microthrombosis model to investigate the pharmacokinetic changes in vivo. Results: DS-1040 Tosylate increased plasma D-dimer levels in a dose-dependent manner. ED50 and EDmax were 122 and 221nM, respectively. Methods: DS-1040 Tosylate (0.25, 0.5, 1, 2, 4, 8, 16 mg/kg; oral administration) was administered to mice with microthrombosis model to investigate the pharmacokinetic changes in vivo. Results: DS-1040 Tosylate increased plasma D-dimer levels, with EC50 and ECmax values of 114 and 231 nmol/L, respectively.[1] | 
| Synonyms | DS1040 Tosylate | 
| Molecular Weight | 465.61 | 
| Formula | C23H35N3O5S | 
| Cas No. | 1335138-89-0 | 
| Smiles | S(=O)(=O)(O)C1=CC=C(C)C=C1.C([C@H](CCCN)C(O)=O)C1=CN(C=N1)[C@H]2CC[C@H](C)CC2 | 
| Relative Density. | no data available | 
| Storage | keep away from moisture | store at 4°C | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 40 mg/mL (85.91 mM), Sonication is recommended.  DMSO: 80 mg/mL (171.82 mM), Sonication is recommended.  | ||||||||||||||||||||||||||||||||||||||||
| Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
| H2O/DMSO 
 DMSO 
 | |||||||||||||||||||||||||||||||||||||||||
 For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .  A total of 10 animals were administered, and the formula you used is 5%
 A total of 10 animals were administered, and the formula you used is 5%  DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first. main solution, add 300 μLPEG300
 main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O
 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
 mix well and clarify
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.